Genpact Limited (NYSE:G) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP decreased its position in Genpact Limited (NYSE:G) by 49.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,821 shares of the business services provider’s stock after selling 74,798 shares during the period. Bridgewater Associates LP’s holdings in Genpact were worth $3,012,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its holdings in shares of Genpact by 34.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider’s stock valued at $107,065,000 after acquiring an additional 847,249 shares during the last quarter. Vulcan Value Partners LLC grew its position in Genpact by 22.2% during the 2nd quarter. Vulcan Value Partners LLC now owns 1,567,428 shares of the business services provider’s stock worth $50,456,000 after purchasing an additional 284,842 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Genpact by 8.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,512,259 shares of the business services provider’s stock valued at $48,680,000 after buying an additional 122,993 shares during the last quarter. Greenhaven Associates Inc. lifted its holdings in shares of Genpact by 14.1% in the 2nd quarter. Greenhaven Associates Inc. now owns 1,240,775 shares of the business services provider’s stock valued at $39,941,000 after buying an additional 153,140 shares during the period. Finally, Pzena Investment Management LLC boosted its stake in shares of Genpact by 130.3% in the second quarter. Pzena Investment Management LLC now owns 1,163,870 shares of the business services provider’s stock worth $37,465,000 after buying an additional 658,560 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.

Insider Buying and Selling at Genpact

In other news, CEO Balkrishan Kalra sold 9,000 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at $12,407,545.60. This represents a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.80% of the company’s stock.

Analysts Set New Price Targets

G has been the subject of several recent research reports. Needham & Company LLC lifted their price target on Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, November 11th. TD Cowen boosted their target price on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research note on Friday, November 8th. BMO Capital Markets raised their price target on shares of Genpact from $38.00 to $42.00 and gave the company a “market perform” rating in a research report on Monday, August 12th. Jefferies Financial Group lifted their price objective on shares of Genpact from $35.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 9th. Finally, Robert W. Baird increased their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $42.33.

Genpact Stock Down 0.7 %

Shares of NYSE G opened at $46.16 on Friday. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $47.98. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. The company’s 50-day simple moving average is $41.17 and its 200-day simple moving average is $37.00. The firm has a market cap of $8.14 billion, a price-to-earnings ratio of 12.68, a price-to-earnings-growth ratio of 1.60 and a beta of 1.13.

Genpact Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 9th will be paid a dividend of $0.1525 per share. The ex-dividend date is Monday, December 9th. This represents a $0.61 annualized dividend and a yield of 1.32%. Genpact’s dividend payout ratio (DPR) is currently 16.76%.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.